Cargando…
Cell state‐directed therapy – epigenetic modulation of gene transcription demonstrated with a quantitative systems pharmacology model of temozolomide
Cancer therapy continues to be plagued by modest therapeutic advances. This is particularly evident in glioblastoma multiforme (GBM) wherein treatment failures are attributed to intratumoral heterogeneity (ITH), a dynamic process of cell state transitions or plasticity. To address ITH, we introduce...
Autores principales: | Saini, Anshul, Ballesta, Annabelle, Gallo, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014061/ https://www.ncbi.nlm.nih.gov/pubmed/36642831 http://dx.doi.org/10.1002/psp4.12916 |
Ejemplares similares
-
Epigenetic instability may alter cell state transitions and anticancer drug resistance
por: Saini, Anshul, et al.
Publicado: (2021) -
pH as a potential therapeutic target to improve temozolomide antitumor efficacy : A mechanistic modeling study
por: Stéphanou, Angélique, et al.
Publicado: (2019) -
Multiscale Design of Cell-Type–Specific Pharmacokinetic/Pharmacodynamic Models for Personalized Medicine: Application to Temozolomide in Brain Tumors
por: Ballesta, A, et al.
Publicado: (2014) -
CUL4B Promotes Temozolomide Resistance in Gliomas by Epigenetically Repressing CDNK1A Transcription
por: Ye, Xiang, et al.
Publicado: (2021) -
Modulation of gene-specific epigenetic states and transcription by non-coding RNAs
por: Morris, Kevin V.
Publicado: (2011)